Issues

Volume 2 - Issue 2, Winter 2008

Sun, 21 Dec 2008

media_01-1.gif

In this Issue

  • Table of contents
  • Editorial Board
  • Download pdf (print optimised)
  • Download pdf (screen optimised)

Editorial

  • Editorial

    Dear Readers, Medical technology is constantly widening the diagnostic and therapeutic horizons in our professional lives. It provides hope for the patient who looks to the rapidly developing medical technology of tomorrow for a solution to his or her complex health problems today. Simultaneously, medical technology represents a remarkable sector of corporate activity, on both sides of the Atlantic. Focu...

    READ MORE

EU News

  • WHO Governing Body to Make Decisions Affecting Health Systems

    The need to strengthen health systems so that they can respond quickly and flexibly to the growing number of new challenges was on the agenda of the WHO’s European governing body, the WHO Regional Committee for Europe. Attended by over 250 health officials from the WHO European Region, its annual session took place in Tbilisi, Georgia from September 15 - 18. The Regional Committee considered several cr...

    READ MORE

Cover Story: Patient Access to Medical Technology In Europe

Features

  • Cardiac CT: A Snapshot of Coming Developments

    The primary reason for the development of cardiac CT was the expectation that CT could replace diagnostic cardiac catheterisation procedures, an expensive study that, due to the need for arterial catheterisation, has a relatively high complication rate. But where will this relatively new technology go, and how will it improve imaging techniques for cardiologists? This article explores the issues involved....

    READ MORE
  • Setting Up a Heart Failure Clinic: Ensuring Operational Efficiency

    Why was it Decided to Set Up a Heart Failure Clinic at the UZ Middelheim? This hospital is a university affiliated facility with a large interventional cardiovascular programme of more than 4,000 diagnostic coronary angiograms, and more than 2,000 PCIs per year. Over the years, improved prognosis of acute coronary syndromes has led to an increased burden of chronic heart failure. The older age of the hear...

    READ MORE
  • Review of Anticoagulants:

    Improving the Management of Thromboembolitic Prevention in Routine PracticeAnticoagulants are recommended for a wide variety of indications, including the prevention of venous thromboembolism (VTE; comprising deep vein thrombosis [DVT] and pulmonary embolism [PE]), the treatment of VTE, stroke prevention in patients with atrial fibrillation (AF) and secondary prevention of major ischaemic outcomes in patien...

    READ MORE
  • Management Challenges of Cardiologists in Latvia: Taking Steps to Modernise Facilities

    In the twenty years since the demise of the Soviet Union, Latvia has transformed itself, gaining its independence not only politically but also in medicine. While formerly, research, innovations and financial investments were concentrated in Moscow and less in the Baltic States, in present times Latvia is a member of the European Union, is independent, and its citizens can make their own decisions and contr...

    READ MORE

Country Focus: Cardiology in the United States

  • Overview of the Healthcare System in the United States: Disparity in Access Continues to Provoke

    The United States is the only wealthy industrialised nation without a universal healthcare system, according to the Institute of Medicine of the National Academy of Sciences. It has a mixed system of public and private insurance. Most working age Americans have private health insurance through their employers. Private health insurance covers about 57% of the population, while only 27% is insured through gov...

    READ MORE
  • Motivating Patients to Get Involved in Their Health:

    Euro Aspire III Trial Mirrors US Struggle to Empower Patients This article addresses early identification and prevention of cardiovascular disease, to highlight the challenges in motivating patients to participate in their health and well being and focus on motivating insurance companies and national healthcare to empower, enable and encourage better health. National policies have been ineffective at promot...

    READ MORE
  • Profile of the American Heart Association: Building Healthier Lives

    The American heart association mission is building healthier lives, free of cardiovascular diseases and stroke. To accomplish this, its volunteers and organisation are involved in an extremely broad range of activities. The activities of the Association systematically attack the problem of cardiovascular disease across the knowledge spectrum in the following ways: Discovering knowledge through research;...

    READ MORE

Healthcare Economics

  • Marketing Your Healthcare Services: What You Need to Know

    Healthcare’s once-upon-a-time days are gone. Simply being the nearby hospital does not automatically stake your organisation’s financial claim. So, in an increasingly competitive industry, what is the ideal way to market a hospital or healthcare service to consumers—who are often no longer just patients? Throughout Europe, healthcare has to date remained largely insulated from normal market mechanism...

    READ MORE

Industry News: An Overview of the Latest Updates from Technology & Industry

  • CV Therapeutics Announces License Agreement

    The Menari Group have been granted exclusive rights to Ranexa. The agreement grants rights to Menarini for Ranexa in 68 countries, including the 27 countries of the European Union, the Commonwealth of Independent States and certain countries in Central and South America. The deal included an upfront payment of 70 million dollars and further payments could amount to 315 million dollars. Ranexa will be launch...

    READ MORE
  • EU Approves New Treatment

    Tracleer®, a dual endothelin receptor antagonist has been approved in the European Union for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (WHO FC II). A clinical study of patients with mildly symptomatic WHO FC II led to approval and revealed that even patients with mild symptoms are at risk of rapid deterioration. Tracleer delays disease progression in these patients a...

    READ MORE
  • Biotronik Home Monitoring Approved in Europe

    BIOTRONIK’s wireless remote monitoring technology for patients with cardiac devices has been approved in Europe. It identifies patients with the most clinically relevant events to streamline clinic workflow and improve patient care. The traffic-light severity-based display of patients’ status identifies the most important information with one click and allows the review of the clinical status of patient...

    READ MORE
  • Terarecon Releases New Device

    TeraRecon has announced the release of new innovations in its flagship Aquarius iNtuition™ platform. Showcased in September at the ASNC annual meeting in Boston, this client server aims to improve efficiency within cardiac imaging. The new device is said to improve speed and accuracy in CT technology. It is workflow orientated, “available anywhere” through the healthcare enterprise and integrates with...

    READ MORE
  • Anticlotting Medicine Lowers Incidence of Heart Attack

    New data shows anticlotting medicine Tirofiban (AGGRASTAT®) lowers incidence of heart attack in patients who respond poorly to aspirin or Clopidogrel after elective coronary angioplasty. Dr Marco Valgimigli, Chair of Cardiology, University of Ferrara, Italy and the principal investigator of the study emphasised the significance of the findings as they “Demonstrate a proof of concept for a new treatment s...

    READ MORE
  • Physio-Control Receives FDA Clearance for Life Pak 20e Defibrillator/Monitor Within the US

    Physio-Control, a wholly owned subsidiary of Medtronic Inc. received clearance from the FDA on October 3, 2008 to market the LIFEPAK 20e defibrillator / monitor within the US. It is an enhancement of the LIFEPAK 20 with a more powerful lithium-ion battery doubling ECG monitoring time. It is a non-evasive way to monitor the oxygenisation of a patient’s haemoglobin and has been developed so it can be easily...

    READ MORE
  • Pfizer Research Reshuffle

    The Wall Street Journal has reported that Pfizer have abandoned the development of medicines for heart diseases. In the past Pfizer dominated the cardiovascular drugs sector with Lipitor being named as the worlds best selling drug in 2007. Due to a reorganisation of research they will be leaving drugs such as Lipitor to focus on other programmes including oncology and Alzheimers. They have however confirmed...

    READ MORE
  • Radi Medical Systems Inc. Announces Clearance of Pressure Wire Certus

    Previously only cleared for use in the coronary and peripheral blood vessels, PressureWire Certus can now be used to assess pressure measurements across heart valves and into various chambers of the heart. It can also be used in the assessment of Fractional Flow Reserve (FFR). FFR expresses the maximum achievable blood flow in a coronary artery with abnormal stenosis as a fraction of maximum blood flow in t...

    READ MORE
  • St Jude Medical Announce Clearance of Implantable Device

    The SJM Confirm™ implantable cardiac monitor (ICM) is a compact device designed to help physicians detect abnormal heart rhythms in patients with unexplained symptoms. It enables the evaluation of heart rhythm signals over a longer period of time compared to standard monitoring tests and it is the smallest ICM available which can be implanted in an outpatient procedure under local anaesthetic. Patients ca...

    READ MORE
  • Cypher Sirolimus- Eluting Coronary Stent Comparable to Bypass Surgery

    Cordis have released clinical data indicating that percutaneous coronary intervention with the CYPHER sirolimuseluting coronary stent is comparable to bypass surgery in key safety measures in patients with diabetes and multi-vessel disease. The data was recently presented at the European Society of Cardiology meeting. It is the only drug-eluting stent with such randomised clinical data indicating that it is...

    READ MORE
  • University of Florida Medical Center Install Toshiba Aquilion One Dynamic Volume CT

    Shands HealthCare at the University of Florida medical centre have installed the Toshiba Aquilion ONE dynamic volume CT. This may change the way hospitals and physicians treat and diagnose patients with cardiovascular and neurological disease. Aquilion ONE can perform single heart beat studies and capture organ perfusion, actions that cannot be performed by other systems. The system uses 320 ultra-high reso...

    READ MORE
  • Philips and Steris Alliance to Provide Hybrid Surgical Rooms

    These hybrid surgical rooms will provide optimal imaging during open and minimally invasive cardiovascular surgical procedures in a bid to enhance workflow. The combination of Philips cardiovascular x-ray systems and Steris HD 360 suites technologies and design service aims to create a flexible treatment environment in a single suite. It will in turn provide hospitals with opportunities for surgical innovat...

    READ MORE
  • Trials Show CRT Delays First Hospitalisation

    Medtronic sponsored trials by REVERSE and PARTNERS HF have shown that cardiac resynchronisation therapy (CRT) delays the time to the first hospitalisation or death in patients with mild heart failure, and devices equipped with OptiVol® Fluid Status Monitoring identified patients who were at a significantly higher risk of having heart failure events in the near future. Although normally for patients with mo...

    READ MORE

Cardiology Leaders